Receptors for PTH and PTHrP:: their biological importance and functional properties

被引:206
作者
Mannstadt, M
Jüppner, H
Gardella, TJ
机构
[1] Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Pediat, Endocrine Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
关键词
parathyroid hormone; peptide hormone family; class II G protein-coupled receptor; receptor binding; signal transduction; structure-activity relationship; receptor mutagenesis; photochemical cross-linking; constitutively active receptor; receptor mutations in human disease; parathyroid hormone-related peptide;
D O I
10.1152/ajprenal.1999.277.5.F665
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Receptors for PTH and PTHrP: their biological importance and functional properties. The type 1 receptor (PTH1R) for parathyroid hormone (PTH)and parathyroid hormone-related peptide (PTHrP) is a G protein-coupled receptor that is highly expressed in bone and kidney and mediates in these tissues the PTH-dependent regulation of mineral ion homeostasis. The PTH1R also mediates the paracrine actions of PTHrP, which play a particularly vital role in the process of endochondral bone formation. These important functions, the likely involvement of the PTH1R in certain genetic diseases affecting skeletal development and calcium homeostasis, and the potential utility of PTH in treating osteoporosis have been the driving force behind intense investigations of both the receptor and its peptide ligands. Recent lines of work have led to the identification of constitutively active PTH1Rs in patients with Jansen's metaphyseal chondrodysplasia, the demonstration of inverse agonism by certain ligand analogs, and the discovery of the PTH-2 receptor subtype that responds to PTH but not PTHrP. As reviewed herein, a detailed exploration of the receptor-ligand interaction process is currently being pursued through the use of site-directed mutagenesis and photoaffinity cross-linking methods; ultimately, such work could enable the development of novel PTH receptor ligands that have therapeutic value in treating diseases such as osteoporosis and certain forms of hypercalcemia.
引用
收藏
页码:F665 / F675
页数:11
相关论文
共 124 条
[11]   Developmental upregulation of human parathyroid hormone (PTH) PTH-related peptide receptor gene expression from conserved and human-specific promoters [J].
Bettoun, JD ;
Minagawa, M ;
Hendy, GN ;
Alpert, LC ;
Goodyer, CG ;
Goltzman, D ;
White, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :958-967
[12]   Cloning and characterization of the promoter regions of the human parathyroid hormone (PTH) PTH-related peptide receptor gene: Analysis of deoxyribonucleic acid from normal subjects and patients with pseudohypoparathyroidism type 1b [J].
Bettoun, JD ;
Minagawa, M ;
Kwan, MY ;
Lee, HS ;
Yasuda, T ;
Hendy, GN ;
Goltzman, D ;
White, JH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1031-1040
[13]   Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies [J].
Bisello, A ;
Adams, AE ;
Mierke, DF ;
Pellegrini, M ;
Rosenblatt, M ;
Suva, LJ ;
Chorev, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) :22498-22505
[14]  
Blind E, 1996, J BONE MINER RES, V11, P578
[15]   AGONIST-STIMULATED PHOSPHORYLATION OF THE G-PROTEIN COUPLED RECEPTOR FOR PARATHYROID-HORMONE (PTH) AND PTH-RELATED PROTEIN [J].
BLIND, E ;
BAMBINO, T ;
NISSENSON, RA .
ENDOCRINOLOGY, 1995, 136 (10) :4271-4277
[16]   A CASE OF LETHAL CONGENITAL DWARFISM WITH ACCELERATED SKELETAL MATURATION [J].
BLOMSTRAND, S ;
CLAESSON, I ;
SAVESODERBERGH, J .
PEDIATRIC RADIOLOGY, 1985, 15 (02) :141-143
[17]  
Bringhurst FR., 1989, ENDOCRINOLOGY, P805
[18]   CLONING AND CHARACTERIZATION OF AN EXTRACELLULAR CA2+-SENSING RECEPTOR FROM BOVINE PARATHYROID [J].
BROWN, EM ;
GAMBA, G ;
RICCARDI, D ;
LOMBARDI, M ;
BUTTERS, R ;
KIFOR, O ;
SUN, A ;
HEDIGER, MA ;
LYTTON, J ;
HEBERT, SC .
NATURE, 1993, 366 (6455) :575-580
[19]   PARATHYROID-HORMONE RECEPTOR INTERACTIONS [J].
CAULFIELD, MP ;
ROSENBLATT, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1990, 1 (03) :164-168
[20]  
CHENG L, 1981, J BIOL CHEM, V256, P1556